Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
NCT01527370
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Shingles
Interventions
BIOLOGICAL:
Zoster Vaccine Live
Sponsor
Merck Sharp & Dohme LLC